Back to search

Article

ABCC5 Gene Variant c.1146A>G Reduces MRP5 Expression and Can be a Potential Marker to Manage Cilostazol Induced Headache

2020-03-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Patients taking cilostazol, a representative phosphodiesterase type III inhibitor used for vasodilation, occasionally complain of headaches. Cerebral arteriolar relaxation, due to an increase in intracellular cAMP or cGMP, is believed to be associated with a severe form of cilostazol-induced headaches. Multidrug resistance protein 5 (MRP5) is an important regula...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e2939ae-11c6-52f3-80d9-881d26985b04
DOI
10.21203/rs.3.rs-18650/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ABCC5 Gene Variant c.1146A&gt;G Reduces MRP5 Expression and Can be a Potential Marker to Manage Cilostazol Induced HeadacheDOI 10.21203/rs.3.rs-18650/v1
Select a neighboring publication to make it the new centre.